Gregory-Evans Kevin, Kolawole Olubayo U, Molday Robert S, Gregory-Evans Cheryl Y
Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Department Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
Ophthalmologica. 2024;247(4):231-240. doi: 10.1159/000540361. Epub 2024 Jul 23.
Conclusive molecular genetic diagnoses in inherited retinal diseases remains a major challenge due to the large number of variants of uncertain significance (VUS) identified in genetic testing. Here, we determined the genotypic and phenotypic spectrum of ABCA4 gene variants in a cohort of Canadian inherited retinal dystrophy subjects.
This retrospective study evaluated 64 subjects with an inherited retinal dystrophy diagnosis with variants in the ABCA4 gene. Pathogenicity of variants was assessed by comparison to genetic databases and in silico modelling. ABCA4 variants classified as VUS were further evaluated using a cryo-electron structural model of the ABCA4 protein to predict impact on protein function and were also assessed for evolutionary conservation.
Conclusive disease-causing biallelic ABCA4 variants were detected in 52 subjects with either Stargardt's disease, cone-rod dystrophy, macular dystrophy, or pattern dystrophy. A further 14 variants were novel comprising 1 nonsense, 1 frameshift, 3 splicing, and 9 missense variants. Based on in silico modelling, protein modelling and evolutionary conservation from human to zebrafish, we re-classified 5 of these as pathogenic and a further 3 as likely pathogenic. We also added to the ABCA4 phenotypic spectrum seen with four known pathogenic variants (c.2161-2A>G; Leu296Cysfs*4; Arg1640Gln; and Pro1380Leu).
This study expands the genotypic and phenotypic spectrum of ABCA4 disease-associated variants. By panel-based genetic testing, we identified 14 novel ABCA4 variants of which 8 were determined to be disease-causing or likely disease-causing. These methodologies could circumvent somewhat the need for labour intensive in vitro and in vivo assessments of novel ABCA4 variants.
由于基因检测中发现大量意义不明确的变异(VUS),遗传性视网膜疾病的确切分子遗传学诊断仍然是一项重大挑战。在此,我们确定了一组加拿大遗传性视网膜营养不良患者中ABCA4基因变异的基因型和表型谱。
这项回顾性研究评估了64名被诊断为遗传性视网膜营养不良且ABCA4基因存在变异的患者。通过与基因数据库比较和计算机模拟来评估变异的致病性。对于被分类为VUS的ABCA4变异,使用ABCA4蛋白的冷冻电子结构模型进一步评估以预测对蛋白质功能的影响,并评估其进化保守性。
在52名患有斯塔加特病、锥杆营养不良、黄斑营养不良或图案营养不良的患者中检测到了决定性的致病双等位基因ABCA4变异。另外14个变异是新发现的,包括1个无义变异、1个移码变异、3个剪接变异和9个错义变异。基于计算机模拟、蛋白质建模以及从人类到斑马鱼的进化保守性,我们将其中5个重新分类为致病性变异,另外3个重新分类为可能致病性变异。我们还扩充了与四个已知致病变异(c.2161-2A>G;Leu296Cysfs*4;Arg1640Gln;和Pro1380Leu)相关的ABCA4表型谱。
本研究扩展了ABCA4疾病相关变异的基因型和表型谱。通过基于基因 panel 的检测,我们鉴定出14个新的ABCA4变异,其中8个被确定为致病或可能致病。这些方法可以在一定程度上避免对新的ABCA4变异进行劳动密集型的体外和体内评估的需求。